Chemical Formula: C12H15N3O5S

Chemical Formula C12H15N3O5S

Found 6 metabolite its formula value is C12H15N3O5S

Albendazole-beta-hydroxysulphone

Albendazole-beta-hydroxysulphone

C12H15N3O5S (313.073238)


   

Albendazole-gamma-hydroxysulphone

Albendazole-gamma-hydroxysulphone

C12H15N3O5S (313.073238)


   
   

Amezinium metilsulfate

Amezinium methylsulfate

C12H15N3O5S (313.073238)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors Amezinium metilsulfate has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition ofnoradrenaline and tyramine uptake. Target: alpha and beta-1 receptors Amezinium metilsulfate is a sympathomimetic drug used for the treatment of low blood pressure. Cardiovascular effects of the new sympathomimetic Amezinium metilsulphate are investigated in 25 patients compared with a control group (n = 25). During spinal/epidural anaesthesia 5 mg amezinium is given i.v. if blood pressure dropped greater than 20 mmHg. from starting-point. A significant recovery of blood pressure (epidural anaesthesia: syst 21\%, diast 9\%; spinal anaesthesia: syst 13\%, diast 6.6\%) and a decrease in heart rate (6.8\% resp. 4,5\%) are thought due to peripheral vasoconstriction. Amezinium proves a stimulating drug for alpha- and beta 1-receptors by stabilising the systemic blood pressure in spinal/epidural anaesthesia.

   

S-(4-nitrobenzyl)-L-cysteinylglycine

S-(4-nitrobenzyl)-L-cysteinylglycine

C12H15N3O5S (313.073238)


   

2-[[(2R)-2-amino-3-[(4-nitrophenyl)methylsulfanyl]propanoyl]amino]acetic acid

2-[[(2R)-2-amino-3-[(4-nitrophenyl)methylsulfanyl]propanoyl]amino]acetic acid

C12H15N3O5S (313.073238)